These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 22688498)
1. Infliximab-induced nonspecific interstitial pneumonia. Sen S; Peltz C; Jordan K; Boes TJ Am J Med Sci; 2012 Jul; 344(1):75-8. PubMed ID: 22688498 [TBL] [Abstract][Full Text] [Related]
2. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Schneeweiss S; Korzenik J; Solomon DH; Canning C; Lee J; Bressler B Aliment Pharmacol Ther; 2009 Aug; 30(3):253-64. PubMed ID: 19438424 [TBL] [Abstract][Full Text] [Related]
3. Case records of the Massachusetts General Hospital. Case 33-2008. A 63-year-old woman with dyspnea on exertion. Wiener CM; Muse VV; Mark EJ N Engl J Med; 2008 Oct; 359(17):1823-32. PubMed ID: 18946068 [No Abstract] [Full Text] [Related]
4. Infliximab-induced reactivated Langerhan's cell histiocytosis in a patient with ulcerative colitis. Rodríguez HN; García I; Alba A; Igea F Inflamm Bowel Dis; 2009 Sep; 15(9):1286-7. PubMed ID: 18942740 [No Abstract] [Full Text] [Related]
5. Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Perez-Alvarez R; Perez-de-Lis M; Diaz-Lagares C; Pego-Reigosa JM; Retamozo S; Bove A; Brito-Zeron P; Bosch X; Ramos-Casals M Semin Arthritis Rheum; 2011 Oct; 41(2):256-64. PubMed ID: 21277618 [TBL] [Abstract][Full Text] [Related]
6. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis]. Mocciaro F; Orlando A; Scimeca D; Cottone M Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus. Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441 [TBL] [Abstract][Full Text] [Related]
8. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965 [TBL] [Abstract][Full Text] [Related]
12. [Interstitial pneumonia after infliximab therapy for psoriasis]. Leger S; Etienne M; Duval-Modeste AB; Roussel A; Caron F; Thiberville L Ann Dermatol Venereol; 2011; 138(6-7):499-503. PubMed ID: 21700071 [TBL] [Abstract][Full Text] [Related]
13. A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine. Nagy F; Molnar T; Makula E; Kiss I; Milassin P; Zollei E; Tiszlavicz L; Lonovics J World J Gastroenterol; 2007 Jan; 13(2):316-9. PubMed ID: 17226917 [TBL] [Abstract][Full Text] [Related]
15. Safety of infliximab in 10 years of clinical practice. O'Donnell S; Murphy S; Anwar MM; O'Sullivan M; Breslin N; O'Connor HJ; Ryan BM; O'Morain CA Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):603-6. PubMed ID: 21602689 [TBL] [Abstract][Full Text] [Related]
16. Infliximab as therapeutic option in steroid-refractory ulcerative colitis after kidney transplantation: case report. Temme J; Koziolek M; Bramlage C; Schaefer IM; Füzesi L; Ramadori G; Müller GA; Schwörer H Transplant Proc; 2010 Nov; 42(9):3880-2. PubMed ID: 21094876 [TBL] [Abstract][Full Text] [Related]
17. Review article: Infliximab therapy for inflammatory bowel disease--seven years on. Rutgeerts P; Van Assche G; Vermeire S Aliment Pharmacol Ther; 2006 Feb; 23(4):451-63. PubMed ID: 16441465 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Su C; Salzberg BA; Lewis JD; Deren JJ; Kornbluth A; Katzka DA; Stein RB; Adler DR; Lichtenstein GR Am J Gastroenterol; 2002 Oct; 97(10):2577-84. PubMed ID: 12385442 [TBL] [Abstract][Full Text] [Related]
19. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience. Lawrance IC; Radford-Smith GL; Bampton PA; Andrews JM; Tan PK; Croft A; Gearry RB; Florin TH J Gastroenterol Hepatol; 2010 Nov; 25(11):1732-8. PubMed ID: 21039834 [TBL] [Abstract][Full Text] [Related]
20. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study. Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]